Name | ASTRAFARMA, OOO |
|---|
INN | 2901237312 |
|---|
KPP | 290101001 |
|---|
OGRN | 1132901005137 |
|---|
OKPO | 10371602 |
|---|
Address | 163051, Arkhangel'skaya Oblast', g Arkhangel'sk, ul Voskresenskaya, d. D. 103, of. OFIS 40 |
|---|
Phone | Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | All types of activities | | 52.29 | Additional activity | Service activities incidental to land transportation | | 64.19 | Additional activity | Credit institutions with special functions | | 64.92.2 | Additional activity | Credit institutions with special functions | | 70.22 | Additional activity | Advice on business and management | | 73.11 | Additional activity | Activities of advertising agencies | | 82.99 | Additional activity | Other business support services to businesses and individuals not otherwise specified | | 86 | Additional activity | Health service |
Registration date | 26.04.2013 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po g.Arkhangel'sku |
|---|
|
ASTRAFARMA, OOO (Arkhangelsk Oblast; INN 2901237312) was registered on 26 Apr 2013. The company's authorized capital as of July 1, 2012 was 10000 rub. Principal activities of ASTRAFARMA, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of ASTRAFARMA, OOO dropped in 2023 by 29.53% to 17.67 million RUB from 25.08 million RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 2.04% to 438.92 million RUB from 430.14 million RUB over 2022; cost of goods sold grew by 3.40% to 362.34 million RUB from 350.41 million RUB; sales profit fell by 41.66% to 12.85 million RUB from 22.03 million RUB. 2022
Net profit (RAS) of ASTRAFARMA, OOO over 2022 was the same as in 2021 reaching 25.08 million RUB, the company informed. Revenue increased in the accounting period by 8.35% to 430.14 million RUB from 397.00 million RUB over 2021; cost of goods sold grew by 9.03% to 350.41 million RUB from 321.40 million RUB; sales profit fell by 17.32% to 22.03 million RUB from 26.64 million RUB. 2021
Net profit (RAS) of ASTRAFARMA, OOO grew over 2021 2.05 times to 25.12 million RUB from 12.26 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 2.28% to 397.00 million RUB from 406.26 million RUB in 2020; cost of goods sold decreased by 7.03% to 321.40 million RUB from 345.69 million RUB; sales profit went up 1.98 times to 26.64 million RUB from 13.46 million RUB. 2020
Net profit (RAS) of ASTRAFARMA, OOO dropped in 2020 by 11.16% to 12.26 million RUB from 13.80 million RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 2.50% to 406.26 million RUB from 396.35 million RUB over 2019; cost of goods sold grew by 4.46% to 345.69 million RUB from 330.92 million RUB; sales profit fell by 17.77% to 13.46 million RUB from 16.37 million RUB. 2018
Net profit (RAS) of ASTRAFARMA, OOO dropped in 2018 by 41.19% to 6.13 million RUB from 10.43 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 20.56% to 350.02 million RUB from 290.32 million RUB over 2017; cost of goods sold grew by 24.69% to 292.55 million RUB from 234.63 million RUB; sales profit fell by 39.52% to 5.95 million RUB from 9.83 million RUB. 2017
Net profit (RAS) of ASTRAFARMA, OOO grew over 2017 by 36.79% to 10.43 million RUB from 7.62 million RUB over 2016, the company informed. Revenue increased in the accounting period by 8.44% to 290.32 million RUB from 267.71 million RUB over 2016; cost of goods sold grew by 5.72% to 234.63 million RUB from 221.94 million RUB; sales profit went up 1.63 times to 9.83 million RUB from 6.04 million RUB. 2016
Net profit (RAS) of ASTRAFARMA, OOO grew over 2016 8.56 times to 7.62 million RUB from 890.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period by 40.97% to 267.71 million RUB from 189.90 million RUB over 2015; cost of goods sold grew by 44.56% to 221.94 million RUB from 153.53 million RUB; sales profit made up 6.04 million RUB compared to sales loss of 253.00 thousand RUB. 2014
Net loss (RAS) of Astrafarma, OOO increased 2.16 times to 8.42 million RUB from 3.90 million RUB over 2013, the company informed. Revenue increased in the accounting period 22.30 times to 91.59 million RUB from 4.11 million RUB over 2013; cost of goods sold grew 25.13 times to 78.77 million RUB from 3.13 million RUB; sales loss grew 2.39 times to 9.15 million RUB from 3.83 million RUB. 2013
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|